Diphenyl diselenide protects against diabetic kidney disease through modulating gut microbiota dysbiosis in streptozotocin-induced diabetic rats
2024

Diphenyl Diselenide Helps Diabetic Kidney Disease by Changing Gut Bacteria

Sample size: 50 publication 10 minutes Evidence: moderate

Author Information

Author(s): Wang Xing, Long Dongmei, Peng Xingcan, Li Jiaxuan, Zhou Maoting, Wang Yu, Hu Xianghong

Primary Institution: North Sichuan Medical College

Hypothesis

Does diphenyl diselenide alleviate diabetic kidney disease by inhibiting extracellular matrix production and regulating gut microbiota?

Conclusion

Diphenyl diselenide improves kidney function in diabetic rats by reducing oxidative stress and restoring gut microbiota balance.

Supporting Evidence

  • Diphenyl diselenide reduced blood glucose and improved kidney function in diabetic rats.
  • It decreased the levels of harmful proteins in the kidneys.
  • DPDS improved the diversity of gut bacteria in diabetic rats.
  • Oxidative stress markers were significantly reduced with DPDS treatment.
  • DPDS treatment led to a decrease in extracellular matrix production in the kidneys.

Takeaway

This study shows that a compound called diphenyl diselenide can help protect the kidneys in diabetic rats by fixing the bacteria in their guts and reducing stress in their bodies.

Methodology

Rats were treated with diphenyl diselenide or metformin for eight weeks, and various kidney and gut health indicators were measured.

Limitations

The study did not analyze specific metabolites of gut bacteria or confirm the role of diphenyl diselenide in renal fibrosis using advanced staining techniques.

Participant Demographics

Fifty male Sprague-Dawley rats aged 6-7 weeks.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3389/fphar.2024.1506398

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication